Day: March 9, 2019

Precision BioSciences Enters Into Private Convertible Note Financing

DURHAM, North Carolina, USA, March 9, 2019 – Precision BioSciences (“Precision” or the “Company”), a genome editing company dedicated to improving life (DTIL) through its proprietary ARCUS...